Methods for treating cancer

Details for Australian Patent Application No. 2005280574 (hide)

Owner Allergan, Inc.

Inventors Donovan, Stephen; Brin, Mitchell F.

Agent Davies Collison Cave

Pub. Number AU-A-2005280574

PCT Pub. Number WO2006/025976

Priority 10/929,040 27.08.04 US

Filing date 21 July 2005

Wipo publication date 9 March 2006

International Classifications

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

22 March 2007 PCT application entered the National Phase

  PCT publication WO2006/025976 Priority application(s): WO2006/025976

13 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005280581-Long wavelength thiol-reactive fluorophores

2005280557